Latest Articles
Steve Jones praises his wife after their 'brutal' fertility journey - Daily Mail
Steve Jones praises his wife after their 'brutal' fertility journey Daily Mail
Published: Jan. 21, 2025, 9:36 a.m.
EC approves GSK’s Jemperli-chemo combo for endometrial cancer - Pharmaceutical Technology
EC approves GSK’s Jemperli-chemo combo for endometrial cancer Pharmaceutical Technology
Published: Jan. 21, 2025, 9:35 a.m.
Healthier women, stronger economies: WEF's case for investing in women's health - The New Indian Express
Healthier women, stronger economies: WEF's case for investing in women's health The New Indian Express
Published: Jan. 21, 2025, 7:45 a.m.
Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All - Polity
Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All Polity
Published: Jan. 21, 2025, 7:36 a.m.
Causal analysis of dietary preferences and the risk of endometriosis using large-scale population data - Nature.com
Causal analysis of dietary preferences and the risk of endometriosis using large-scale population data Nature.com
Published: Jan. 21, 2025, 6:16 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post
Published: Jan. 21, 2025, 4:36 a.m.
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning - Frontiers
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning Frontiers
Published: Jan. 21, 2025, 4:35 a.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network
Published: Jan. 20, 2025, 5:08 p.m.
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE
Published: Jan. 20, 2025, 12:33 p.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews
Published: Jan. 20, 2025, 7:28 a.m.
Link copied to clipboard!